Polling Station

Poll 01/07/2019 – 31/07/2019

The femoropopliteal In-Stent-Restenosis

Patient’s characteristics:

Gender: Female

Age: 79 years old

Comorbidity: Arterial hypertension, Dyslipidemia,

Implantation of a bare metal stent right SFA 4 years ago, Debulking and DCB angioplasty for ISR 2 years ago

Symptoms:  Calf claudication after 50 meters

DUS: SFA stent Occlusion

Question #1

Does the Tosaka Class of the ISR influence your treatment strategy?
  • Yes
  • No
  • I am not familiar with the Tosaka Classification
Question #2

Which would be your primary revascularization method for focal SFA ISR?
  • Bare Metal Stent
  • Stent Graft
  • Drug eluting stent
  • Plain Angioplasty
  • Drug coated balloon angioplasty
  • Vessel prep and drug coated balloon angioplasty
Question #3

Which would be your primary revascularization method for long SFA stent occlusion
  • Surgery
  • Endovascular
Question #4

Which would be your primary endovascular treatment option for a popliteal ISR?
  • Bare Metal Stent
  • Stent Graft
  • Drug eluting stent
  • Plain Angioplasty
  • Drug coated balloon angioplasty
  • Vessel prep and drug coated balloon angioplasty
Question #5

Which would be your antithrombotic treatment after endovascular treatment of an occluded bare metal stent in the femoropopliteal segment?
  • Acetylsalicylic acid
  • Clopidogrel
  • Dual antiplatelet therapy
  • Vitamin K antagonist
  • New oral anticoagulant
  • Antiplatelet + Anticoagulant
  • Antiplatelet + Vitamin K antagonist
Question #6

Would you treat an asymptomatic focal ISR in order to prevent an occlusion?
  • Yes
  • No
Question #7

How often do you perform follow up visits after endovascular treatment of an ISR?
  • 3 months intervals
  • 6 mon intervals
  • At 3, 6 and 12 months after the procedure
  • Only in case of symptoms worsening